Medical Fluid Bags Market Size & Share 2023 to 2032

Medical Fluid Bags Market Size

Medical Fluid Bags Market Size crossed USD 3.5 billion in 2022. Driven by the growing health awareness among people across developing economies, the industry is poised to expand at over 5.5% CAGR between 2023 and 2032.

There has been a commendable rise in cognizance of the importance and the need for blood and blood components in lifesaving surgical procedures. As a result, government and non-government bodies worldwide are undertaking numerous blood donation initiatives, campaigns, and programs, which will drive demand for blood bags over the next ten years. For instance, on June 1, 2023, the American Red Cross launched a blood donation drive to help meet the needs of patients requiring blood transfusions. 

Expansion of the healthcare market in developing countries such as China, India, and Brazil is also offering promising opportunities for companies in this space to meet the unmet needs of the regional population. This apart, enhancements in medical training provided to doctors and medical professionals in the region and the rising awareness related to several different medical conditions will considerably boost the market growth. 

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the medical fluid bags market. The growing consumer inclination toward home infusion therapy and the subsequent rise in demand for intravenous (IV) fluids, especially for patients with severe respiratory conditions, led to a surge in the production and consumption of medical fluid bags. Supply chain disruptions, in line with increased healthcare spending, prompted manufacturers to ramp up production and adopt innovative solutions to meet the escalating needs of healthcare facilities worldwide. Further, the American Red Cross encouraged plasma donations to treat COVID-19 patients effectively. This move considerably increased the demand for blood bags to store blood and blood components, positively influencing the industry landscape during the crisis.

Medical Fluid Bags Market Trends

The growing prevalence of chronic diseases and favorable initiatives focused on increasing health awareness among the population will drive the medical fluid bags industry through 2032. Lifestyle-related chronic disorders comprising musculoskeletal diseases, cardiovascular disorders, etc., have been on the surge across the globe. As per the WHO, in 2020, cancer claimed the lives of around 10 million individuals worldwide. Patients suffering from diabetes, liver disorders, and cancer, among others, require long-term hospitalization. This further augments the need for the administration of drugs & medicine and parenteral nutrition, which will favor the adoption of medical fluid bags in the long-term perspective.

Medical Fluid Bags Market Analysis

Regarding the product, the drain bags segment amassed around 29% medical fluid bags market share in 2022 and is estimated to exhibit notable growth over 2023-2032. The growing prevalence of lifestyle diseases such as diabetes and hypertension has led to a surge in end-stage renal disorders. As per the WHO, an estimated around 1.13 billion people across the globe are suffering due to hypertension. Diabetes is the leading cause of chronic kidney failure, followed by hypertension, which may affect around 422 million people worldwide. 

According to the University of California San Francisco research data, an estimated 2 million individuals globally suffer from renal failure. The number is expected to increase at a rate of 5-7% every year. The increasing incidences of acute or chronic renal failure (ARF or CRF) and the subsequent demand for medical fluid bags for urine collection will accelerate business trends.
 

With respect to end-use, the medical fluid bags market share from the hospital segment is expected to be worth over USD 2 billion by 2032. Medical fluid bags, also known as intravenous (IV) bags or infusion bags, are commonly used in healthcare settings to deliver fluids, medications, and nutrients directly into a patient's bloodstream. Increasing hospitalizations due to this surging prevalence rate of diarrheal diseases will propel the demand for medical fluid bags in hospital settings.

As per the WHO report, around 1.7 billion children below 5 years suffer from diarrheal disease annually. These facilities also ensure the availability of advanced diagnostic and medical procedures, such as dialysis, to patients suffering from chronic ailments. Furthermore, high-quality services and better-quality post-operative care across these establishments will augment segment gains. 
 

Regionally, North America medical fluid bags market was valued at over USD 976 million in 2022, attributed to the rise in the geriatric population. According to the U.S. Census Bureau, in 2019, around 54.1 million people were 65 years and above in the U.S. The increasing aging population has contributed significantly to the growing disease burden over the past few years. Additionally, the presence of prominent players such as Thermo Fisher Scientific Inc., B. Braun Melsungen AG, and Amcor Ltd., among others, engaged in novel product development & commercialization will facilitate industrial expansion in North America.

Medical Fluid Bags Market Share

• Baxter International
• B. Braun Medical
• Coloplast
• Macopharma
• Thermo Fisher Scientific
• ConvaTec
   

Medical Fluid Bags Industry News:

• In February 2022, B. Braun acquired Baxa Corporation, a leading provider of IV solutions and devices. This acquisition expanded B. Braun's portfolio and gave it a stronger foothold in the U.S. market.
   
• In April 2022, B. Braun launched the B. Braun Exquisica IV bag, a new generation of IV bags designed to be more user-friendly and comfortable for patients. The bags are made with a soft, flexible material that is easy to grip and have a built-in infusion line that helps prevent leaks.
   

Medical fluid bags market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) and volume (Kilotons) from 2018 to 2032 for the following segments:

By Product, 2018 – 2032 (USD Million & Kilotons)

• Blood Bags
• Intravenous Bags
• Drain Bags
  • Surgical
  • Urinary
• Enema Bags
• Biohazard Disposable Bags
• Breast Milk Bags
• Reagent Bags
• Dialysis Bags
• Others

By Material, 2018 – 2032 (USD Million & Kilotons)

• PVC Compounds
• Polyolefins
• Thermoplastic Elastomers
• Thermoplastic Polyurethanes      

• Others  

By End-use, 2018 – 2032 (USD Million & Kilotons)

• Hospital
• Blood Banks
• Clinics
• Homecare Settings
• Diagnostic Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Iran
  • Turkey